Abstract: Macroporous cement compositions, methods of making the same, and methods of using the same, are described.

Abstract: The application relates to methods for the diagnosis, treatment, and prevention of autoimmune and/or inflammatory disease such as systemic lupus erythematosus (SLE), lupus nephritis, IgA nephropathy, other types of glomerulonephritis.

Abstract: Provided are an anion exchange resin being capable of producing an electrolyte membrane and the like, which have improved chemical properties (durability). For example, used is an anion exchange resin comprising a hydrophobic unit being composed of a plurality of divalent hydrophobic groups repeated via carbon-carbon bond, the divalent hydrophobic group having a plurality of aromatic rings which are connected to each other via a divalent fluorine-containing group; and a hydrophilic unit being composed of a plurality of hydrophilic groups repeated via carbon-carbon bond, the hydrophilic groups being composed of a plurality of aromatic rings which are connected to each other via a divalent hydrocarbon group and/or carbon-carbon bond, and the hydrophilic groups containing an anion exchange group-containing group including a quaternary ammonium salt having a piperidine ring, and wherein the hydrophobic unit and the hydrophilic unit are connected via carbon-carbon bond.

Abstract: Disclosed is a prostate cancer diagnostic biomarker composition including, as an active ingredient, at least one kynurenine pathway metabolite selected from kynurenine and anthranilate. Also disclosed are a prostate cancer diagnostic composition including an agent capable of measuring the level of the biomarker and a prostate cancer diagnostic kit including the prostate cancer diagnostic composition. The use of the prostate cancer diagnostic biomarker composition can significantly improve the accuracy of prostate cancer diagnosis as an alternative or supplement to the use of PSA levels for prostate cancer diagnosis according to the prior art, which has difficulty in ensuring accurate diagnosis. Therefore, the biomarker composition can be widely used in a variety of industrial applications, including medical applications.

Abstract: A method of treating neurodegenerative diseases using hUCB plasma is presented herein. hUCB plasma attenuated the hyperactive response (Group III) and potentiated the normal response in Group I ALS patients, but did not alter that of the non-responders to PHA (Group II). The elevated activity of caspase 3/7 observed in the MNCs from ALS patients was significantly reduced by hUCB plasma treatment. The ability of hUCB plasma to modulate the mitogen cell response and reduce caspase activity suggest that the use of hUCB plasma alone, or with stem cells, may prove useful as a therapeutic in ALS patients. hUCB plasma was shown to increase therapeutic efficacy of MNCs as well as decrease apoptosis of MNCs. The cytokine profile of hUCB plasma supports its usefulness as a sole therapeutic as well as an additive to MNCs.

Abstract: Methods and systems for manufacturing re-entrant structures, such as the structures exhibiting superomniphobic characteristic, in a continuous, well-controlled, high-rate (mass production, volume) manner are disclosed.

Abstract: A method for measuring kinetics of Ca2+ flux in differentially responding T cells that form monolayer on the glass surface in response to antigenic peptides or live target cells comprising: immobilizing T cells labeled with Ca2+ sensitive fluorophore on the glass bottom of a well, covered with capturing antibody or a capturing protein that bind to non-stimulatory T-cell surface receptor; adding to the well a single or multiple peptide epitopes that binds to the cell surface MHC molecules to be presented for recognition by cognate T cells; the stimulatory signal could also be delivered by live target cells that display peptide epitope(s); wherein the recognition of stimulatory of pMHC by the peptide specific T cells leads to increase of intracellular Ca2+ level and fluorescence intensity in the responding T cells.

Abstract: The present invention provides a memory device in which a lower electrode, a seed layer, synthetic antiferromagnetic layers, a separation layer, a magnetic tunnel junction, a capping layer, and an upper electrode are formed on a substrate in a laminated manner, wherein a diffusion barrier is formed between the magnetic tunnel junction and the capping layer. In addition, the present invention provides a memory device in which a lower electrode, a seed layer, synthetic antiferromagnetic layers, a separation layer, a magnetic tunnel junction, a capping layer, and an upper electrode are formed on a substrate in a laminated manner, wherein the seed layer is formed of a material that allows the synthetic antiferromagnetic layers to grow in the FCC (111) direction.

Abstract: Provided is a culture chamber that includes a plurality of recesses each formed of a bottom portion and an opening portion. The bottom portion has a hemispherical shape or a truncated cone shape. The opening portion is defined by a wall that surrounds an area from a boundary between the opening portion and the bottom portion to an end of each of the recesses, the wall having a taper angle in a range from 1 to 20 degrees. An equivalent diameter of the boundary is from 50 ?m to 2 mm and a depth from a bottom of the bottom portion to the end of each of the recesses is from 0.6 or more times to 3 or less times the equivalent diameter, and the wall defining the opening portion forms a surface continuous to the bottom portion. An inclination of the continuous surface changes at the boundary.

Abstract: A liquid crystal photoelectric apparatus includes a first and a second quartz glass substrates, an upper alignment layer disposed between the first and the second quartz glass substrates, a lower alignment layer disposed between the upper alignment layer and the second quartz glass substrate, a liquid crystal material disposed between the upper and the lower alignment layers, a first transparent conductive layer disposed between the upper alignment layer and the first quartz glass substrate and including at least one first main portion and first finger portions extending from the corresponding first main portion and a second transparent conductive layer second transparent conductive layer disposed between the lower alignment layer and the second quartz glass substrate and including a second main portion and second finger portions extending from the second main portion in an extension direction perpendicular to that of the first finger portions. An optical imaging processing system is provided.

Abstract: A first aspect of the present invention is an optical member that blocks straight traveling of light of a second wavelength rather than straight traveling of light of a first wavelength, and is provided with a silicone resin part, and optical material particles dispersed in the silicone resin part, wherein the refractive indexes of the silicone resin part and the optical material particles match at the first wavelength, and do not match at the second wavelength. Consequently, it becomes possible to provide an optical member or the like that selectively transmit a specific wavelength (the first wavelength) by a member different from those of conventional optical elements.

Abstract: The invention relates to a method for preparing a composite metal oxide hollow fibre. A certain stoichiometry of composite metal oxide raw material and a polymer binding agent are added to an organic solvent, and mixed mechanically to obtain an evenly dispersed spinning solution having a suitable viscosity. After defoaming treatment, the spinning solution is extruded through a spinneret and, after undergoing a certain dry spinning process, enters an external coagulation bath; during this period, a phase inversion process occurs and composite metal oxide hollow fibre blanks are formed. The blanks are immersed in the external coagulation bath and the organic solvent is displaced; after natural drying, the blanks undergo a heat treatment process; during this period, polymer burn off, in situ reaction, and in situ sintering processes occur to obtain the composite metal oxide hollow fibre.

Abstract: Described are a genetically modified microorganism and corresponding methods and products. The genetically modified microorganism may include a first gene that encodes an acyl transferase and a second gene that encodes a peptide or protein. One or both of the first and second gene may be heterologous. The genetically modified microorganism may include a modified acyl-CoA biosynthetic pathway configured for one or more of: inducible biosynthesis of an acyl-CoA and over-accumulation of the acyl-CoA. The genetically modified microorganism may be effective upon fermentation to cause acylation of the peptide or protein by the acyl transferase using the acyl-CoA to provide aN-acylated peptide or protein product.

Abstract: A system for producing dry nanoparticles from a liquid includes a closed tubing system which incorporates a mister, heater and an electrostatic collector therein. The system is able to produce dry nanoparticles from liquid-suspensions and from solvent solutions.

Abstract: A method includes generating a bias signal from a first device, and applying the bias signal to a second device, the first device having (a) a superconducting trace and (b) a superconducting quantum interference device (SQUID), in which a first terminal of the SQUID is electrically coupled to a first end of the superconducting trace, and a second terminal of the SQUID is electrically coupled to a second end of the superconducting trace, where generating the bias signal from the first device includes: applying a first signal ?1 to a first sub-loop of the SQUID; and applying a second signal ?2 to a second sub-loop of the SQUID, in which the first signal ?1 and the second signal ?2 are applied such that a value of a superconducting phase of the first device is incremented or decremented by a non-zero integer multiple n of 2?.

Abstract: Implementations described and claimed herein provide systems and methods for managing animal patient during a veterinary procedure. In one implementation, a base has an interior surface, an exterior surface, and an opening. An electrode is disposed in the opening. The electrode is configured to communicate with medical device(s) for monitoring vital(s) of the patient during the procedure. A thermal insulator extends from the base. The thermal insulator forms a housing. An internal cavity is defined within the housing. The foot of the patient is receivable into the internal cavity. The thermal insulator regulates the body temperature of the animal patient during the veterinary procedure by retaining heat within the internal cavity.

Abstract: The present invention provides for a method to produce a deep eutectic solvent (DES) comprising: (a) providing one or more lignin derived monomeric phenol, or a mixture thereof, in a solution, (b) introducing one or more hydrogen acceptors, or a mixture thereof, to the solution, and (c) heating the solution, such that steps (b) and (c) together result in the synthesis of a DES.

Abstract: The system comprises a control module, wherein a medical professional connects to a patient to initiate a telehealth appointment. In certain embodiments, the system comprises a control module accessible to a medical professional, software or an app loaded on the control module and on a second user (patient) device. By running the software or app on both devices, the medical professional and the patient can initiate a connection between the two devices.

Abstract: Provided herein are methods of isolation and identification of post-natal hemogenic endothelial cells. Further provided are substantially purified populations of post-natal hemogenic endothelial cells, compositions of post-natal hemogenic endothelial cells, and methods to utilize hemogenic endothelial cells to regenerate the hematopoietic system in a subject.

Abstract: An integrated circuit includes one or more portions having error detection and error correction circuits and which is operated with operating parameters giving finite non-zero error rate as well as one or more portions formed and operated to provide a zero error rate.